EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of HMGB1 in tumors and its targeted therapy

Jueqiong Chu, Chunling Dong, Bo Li

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189612

DOI: 10.1016/j.bbcan.2026.189612 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Jueqiong Chu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Anatomy and Physiology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Hospital of Stomatology, Jilin University,…. Hauptthemen laut MEDLINE: HMGB1 Protein, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: Jilin Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-mobility group box 1 (HMGB1), a protein with context-dependent pro- and anti-tumor functions, is expressed in tumor cells, tumor-associated macrophages, tumor-associated neutrophils, cancer-associated fibroblasts, and T cells within the tumor microenvironment. The identity of HMGB1 has undergone a transformation from a nuclear architectural protein to a secreted damage-associated molecular pattern with pivotal roles in inflammation and cancer. The heterogeneity of HMGB1 stems from the diversity of post-translational modifications, proteolytic cleavage and lysis, partial independence of domain functions, differences in source tissues and cells, concentration-dependent effects, spatiotemporal distribution and dynamics, and functional diversity. This review summarizes the roles and molecular mechanisms of nuclear, cytoplasmic, and extracellular HMGB1 derived from different cells in tumor progression, its targeted therapy, and its application value as a biomarker, highlighting the regulation of HMGB1 and the downstream signaling pathways of HMGB1. HMGB1 mainly exerts pro-tumor effects during tumor progression via multiple downstream pathways (MAPK, NF-κB, PI3K/AKT, Wnt, STAT3, etc.), while its subtle induction of cell death and enhancement of the immune response demonstrate moderate anti-tumor effects. HMGB1-mediated immune crosstalk regulates the proliferation, growth, migration, invasion, and chemoresistance of tumors. A comprehensive investigation of the spatiotemporal dynamics of HMGB1 and its underlying molecular regulatory mechanisms using cutting-edge technologies, including single-cell RNA sequencing, spatial transcriptomics, and real-time live-cell imaging, will facilitate the development of precise, mechanism-informed therapeutic interventions. Given the multifaceted challenges posed by tumor heterogeneity, the dual pro- and anti-tumor functions of HMGB1, and the limitations of targeting technologies, HMGB1-targeted strategies hold substantial promise for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinNeoplasmsHumansTumor MicroenvironmentMolecular Targeted TherapyAnimalsSignal Transduction

Stichwörter der Autor:innen

HMGB1Targeted therapyTumorTumor microenvironmentTumor-associated macrophages

Substanzen

HMGB1 ProteinHMGB1 protein, human

Autor:innen und Institutionen

  • Department of Oral Anatomy and Physiology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Hospital of Stomatology, Jilin University, Changchun 130021, China.
  • Department of Pulmonary and Critical Care Medicine, Second Hospital, Jilin University, Changchun 130041, China.
  • Department of Oral Anatomy and Physiology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Hospital of Stomatology, Jilin University, Changchun 130021, China. Electronic address: lbo@jlu.edu.cn.

Förderung

  • Jilin Provincial Science and Technology Department

Zitieren

APA

Chu, J., Dong, C., & Li, B. (2026). Role of HMGB1 in tumors and its targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189612. https://doi.org/10.1016/j.bbcan.2026.189612

Vancouver

Chu J, Dong C, Li B. Role of HMGB1 in tumors and its targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189612. doi:10.1016/j.bbcan.2026.189612

BibTeX
@article{Chu2026,
  author = {Chu, Jueqiong and Dong, Chunling and Li, Bo},
  title = {Role of HMGB1 in tumors and its targeted therapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {4},
  pages = {189612},
  doi = {10.1016/j.bbcan.2026.189612}
}
Kostenlos starten →